510(k) · Cleared
ClearedReach Femoral Hip Component
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet, Inc. · LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
Cleared on Dec 4, 1997 as substantially equivalent to K933942 (Depuy, Inc., 1994) and 4 other predicates after a 202-day review. Its family tree reaches back 1 generation to 1994. 1 later device descends from it.
- Decided
- Dec 4, 1997
- Review
- 202 days
- Class
- Class II
- Product code
- LPH
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 1 generation to K921225 (1994). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K984154Apf Porous Coated Line ExtensionBiomet, Inc. · 1999 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K921225 | Integral Total Hip System | Biomet, Inc. | 1994 | — |
| 0 (this device) | K971824 | Reach Femoral Hip Component | Biomet, Inc. | 1997 | — |
| +1 | K984154 | Apf Porous Coated Line Extension | Biomet, Inc. | 1999 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 2 | 0 |
| 1996 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LPH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LPH device
- #1 K233498 Stryker Orthopaedics Hip Systems Labeling Updatescore 24.3 · 20 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | P820024 | Prosthesis, Hip, Hemi-Femoral, Metal FDA lists this PMA only through its supplements; the earliest we hold is P820024/S001 (Mar 16, 1984). Summary page 2…is substantially equivalent to almost all femoral devices on the market in overall design and intended function. Predicate devices include: AML® (Depuy, Warsaw, IN) PMA# P820024000 The Solution System® (Depuy, Warsaw, IN) -510(k)# K933942 -510(k)# K941942 -510(k)# K953703 integral® Total Hip System (Bio… | |
| * | K933942 | Solution Bowed Femoral Hip ProtsthesisSummary page 2…the market in overall design and intended function. Predicate devices include: AML® (Depuy, Warsaw, IN) PMA# P820024000 The Solution System® (Depuy, Warsaw, IN) -510(k)# K933942 -510(k)# K941942 -510(k)# K953703 integral® Total Hip System (Biomet, Inc., Warsaw, IN) -510(k) K921255 0C0o™1 4 === Page 3… | 1994 |
| * | K941942 | Solution HipSummary page 2…all design and intended function. Predicate devices include: AML® (Depuy, Warsaw, IN) PMA# P820024000 The Solution System® (Depuy, Warsaw, IN) -510(k)# K933942 -510(k)# K941942 -510(k)# K953703 integral® Total Hip System (Biomet, Inc., Warsaw, IN) -510(k) K921255 0C0o™1 4 § REALTY o ¢ 4… | 1994 |
| * | K953703 | Depuy Vision Solution Hip ProsthesisSummary page 2…ended function. Predicate devices include: AML® (Depuy, Warsaw, IN) PMA# P820024000 The Solution System® (Depuy, Warsaw, IN) -510(k)# K933942 -510(k)# K941942 -510(k)# K953703 integral® Total Hip System (Biomet, Inc., Warsaw, IN) -510(k) K921255 0C0o™1 4 § REALTY o ¢ 4, C DEPARTMENT OF… | 1996 |
| * | K921225 | Integral Total Hip System Our OCR of the scanned summary read K921255, FDA’s number for Philips BV26 Mobile C-Arm Stand (Philips Medical Systems, Inc.). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “integral® Total Hip System”. | 1994 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K984154 | Apf Porous Coated Line Extension | 1999 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All LPH devicesLPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LPH
12in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LPH
153in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LPH
4in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LPH
6,163in 2025
MAUDE reports naming product code LPH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 116 | 16 | 509 |
| 2008 | 10 | 86 | 1 | 706 |
| 2009 | 3 | 112 | 2 | 1,156 |
| 2010 | 15 | 100 | 22 | 2,007 |
| 2011 | 16 | 110 | 26 | 3,320 |
| 2012 | 25 | 76 | 30 | 3,785 |
| 2013 | 11 | 135 | 9 | 5,002 |
| 2014 | 20 | 129 | 3 | 5,163 |
| 2015 | 18 | 111 | 1 | 5,830 |
| 2016 | 10 | 150 | 8 | 4,900 |
| 2017 | 12 | 121 | 14 | 5,312 |
| 2018 | 9 | 145 | 2 | 5,954 |
| 2019 | 22 | 164 | 8 | 7,130 |
| 2020 | 7 | 164 | 6 | 5,429 |
| 2021 | 8 | 410 | 4 | 5,978 |
| 2022 | 14 | 247 | 2 | 5,223 |
| 2023 | 10 | 111 | 2 | 5,345 |
| 2024 | 6 | 92 | 1 | 5,626 |
| 2025 | 12 | 153 | 4 | 6,163 |
| 2026 | 8 | 256 | 2 | — |
What is it indicated for?
The Reach Femoral Component is intended for use in reconstruction of the hip joint due to damage caused by trauma or degenerative disease and in cases where previous hip replacement component failed. The device is intended for cemented application for general use and non-cemented application in skeletally mature individuals undergoing primary surgery for rehabilitating hip joints damaged as a result of non-inflammatory degenerative joint disease or any of its composite diagnosis. The device is a single use implant. Use with a Biomet Ceramic Modular Head component or Hetal%ic Modular Head component with appropriate matching Type I Taper.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K971824 · printed Nov 4, 2026
Cite this page
510(k) Report. “K971824: Reach Femoral Hip Component.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K971824
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026